Physician profile
Christopher Coram
NPI 1134726391
$941.70
in general payments reported to CMS, 2019-2025
19 companies · $20.52 in 2025
The $20.52 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $433 · 2022: $408 · 2023: $40.18 · 2024: $39.93 · 2025: $20.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $205.82 | 2022 | |
| Edwards Lifesciences Corporation | $129.09 | 2022 | |
| Abbvie INC. | $62.62 | 2021-2022 | |
| Grifols USA, LLC | $62.48 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $61.14 | 2022-2024 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $55.75 | 2021 | |
| Boston Scientific Corporation | $55.09 | 2021-2024 | Varithena Administration Pack |
| Lilly USA, LLC | $50.73 | 2021 | |
| Medtronic, INC. | $44.23 | 2021-2023 | Venaseal |
| Scilex Pharmaceuticals INC. | $37.68 | 2021 | |
| Collegium Pharmaceutical, INC. | $34.57 | 2021 | |
| Pfizer INC. | $29.92 | 2021 | |
| Fidia Pharma USA INC. | $20.52 | 2025 | Hymovis, Triluron |
| Kerecis Limited | $18.56 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bioventus LLC | $17.42 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $15.97 | 2021 | |
| Allergan, INC. | $15.06 | 2021 | |
| Eisai INC. | $12.83 | 2021 | |
| Biodelivery Sciences International, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Coram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.